The advent of new imaging modalities has greatly aided the understanding of neovascular age-related macular degeneration (AMD). Dr Roberto Gallego-Pinazo claims that much of this progress can be attributed to structural optical coherence tomography (OCT). In this interview, filmed at AAO 2018, Dr Gallego-Pinazo discusses the importance of structural OCT and other types of imaging in the diagnosis and treatment of neovascular AMD. He also describes how fluorescein angiography has made it possible to divide neovascularisations into classic and occult, and how structural OCT has advanced this further, allowing the differentiation of neovascular subtypes 1, 2 and 3. Finally, Dr Gallego-Pinazo discusses how better education is required in terms of analysing the information provided by structural OCT in order to determine accurate treatment endpoints, and how self-monitoring devices and telemedicine are the next step forward in neovascular AMD.
1. What are the most useful imaging modalities in the diagnosis and monitoring of neovascular age-related macular degeneration (AMD)? (0:11)
2. How has multimodal imaging impacted on our understanding of neovascular AMD? (0:44)
3. How has these new insights affected the classification of neovascular AMD and what are the clinical implications of this? (1:45)
4. What biomarkers of neovascular activity have proven useful in multimodal imaging? (2:48)
5. What are the remaining unmet needs in this area? (3:45)
Speaker disclosures: Roberto Gallego-Pinazo has nothing to disclose in relation to this interview.
Filmed at the American Academy of Ophthalmology (AAO) 2018 Annual Meeting, Chicago, IL, US, 27–30 October 2018.
Share this Video
Related Videos In Retina/Vitreous
Tommaso Rossi, EURETINA 2020 – Novel Instrument for Internal Limiting Membrane
We were delighted to catch up with Prof. Tommaso Rossi, who talked us through his presentation at EURETINA 2020 concerning a novel instrument for internal limiting membrane, amniotic and retinal flap manipulation. Questions What is the rationale for the use of amniotic membrane grafts in vitreoretinal surgery, and in what ophthalmic indications are they used? […]
Peter Stalmans, EURETINA 2020 – End-stage Retinitis Pigmentosa Patients Implanted with 3D–neural Interface Retinal Prosthesis
Prof. Peter Stalmans (University Hospitals, Leuven, Belgium) talked us through his presentation at EURETINA on first reported clinical results from end-stage retinitis pigmentosa patients implanted with an innovative 3D neural interface retinal prosthesis. Questions Could you give us an overview of advances in retinal prosthesis approaches in the treatment of advanced retinitis pigmentosa […]
Jost Jonas, EURETINA 2019 – Myopia: Epidemiology, Histology & Clinics
It was fantastic to meet up with Jost Jonas (Ruprecht-Karls University) to discuss the Keynote Lecture ‘Myopia: Epidemiology, Histology & Clinics’ he presented at this year’s meeting. Support: No funding was received in the production of this video. Disclosures: Jost Jonas has nothing to disclose in relation to this video.
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!